TransCode Therapeutics (RNAZ) Earnings Date, Estimates & Call Transcripts $6.90 -0.07 (-1.00%) Closing price 04:00 PM EasternExtended Trading$6.96 +0.05 (+0.80%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Earnings Summary TransCode Therapeutics posted Q4 2024 earnings on May 21, 2025, reporting an EPS of -$0.60, which topped the consensus estimate of -$2.00 by $1.40. With a trailing EPS of $0.00, TransCode Therapeutics' earnings are expected to grow next year, from ($4.76) to ($4.37) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)Powered by Latest Q4 Earnings DateMay. 21EstimatedConsensus EPS (May. 21) -$2.00 Actual EPS (May. 21) -$0.60 Beat By $1.40 Get TransCode Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransCode Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNAZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. TransCode Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$56.00-$56.00-$56.00Q2 20251-$8.68-$8.68-$8.68Q3 20251-$9.24-$9.24-$9.24Q4 20251-$10.08-$10.08-$10.08 TransCode Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/21/2025Q4 2024-$2.00-$0.60+$1.40-$2.51$0.30M-8/14/2024Q2 2024-$535.92-$683.76 -$147.84-$0.74--5/15/2024Q1 2024-$646.80-$600.60+$46.20-$0.65--11/14/2023Q3 2023-$55,440.00-$62,092.80 -$6,652.80-$1.68--8/14/2023Q2 2023-$125,294.40-$121,598.40+$3,696.00-$3.29-- TransCode Therapeutics Earnings - Frequently Asked Questions When did TransCode Therapeutics announce their last quarterly earnings? TransCode Therapeutics (NASDAQ:RNAZ) last announced its quarterly earning data on Wednesday, May 21, 2025. Learn more on RNAZ's earnings history. Did TransCode Therapeutics beat their earnings estimates last quarter? In the previous quarter, TransCode Therapeutics (NASDAQ:RNAZ) reported ($0.60) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.00) by $1.40. Learn more on analysts' earnings estimate vs. RNAZ's actual earnings. How much profit does TransCode Therapeutics generate each year? TransCode Therapeutics (NASDAQ:RNAZ) has a recorded net income of -$18.55 million. RNAZ has generated $0.00 earnings per share over the last four quarters. What is TransCode Therapeutics's EPS forecast for next year? TransCode Therapeutics's earnings are expected to grow from ($4.76) per share to ($4.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies Enlivex Therapeutics Earnings CASI Pharmaceuticals Earnings Passage Bio Earnings Tempest Therapeutics Earnings BioAtla Earnings Lisata Therapeutics Earnings Cyclacel Pharmaceuticals Earnings Vor Biopharma Earnings Clene Earnings Relmada Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades This page (NASDAQ:RNAZ) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
